Efficacy and Safety of a Novel Anhydrous 0.1% Retinal-Based Concentrate with Hydrophilic Actives for Photoaged Skin: A Six-Week Prospective Study

Background: Skin aging is influenced by intrinsic factors such as genetics and cellular decline, and extrinsic factors including UV exposure, pollution, and lifestyle. Cosmetic or over-the-counter retinoids, particularly retinal (retinaldehyde), have shown strong efficacy in reducing photoaging signs—such as fine lines, wrinkles, and pigmentation—while offering improved tolerability compared to prescription-based retinoids like all-trans retinoic acid. However, their instability in formulations and limited bioavailability when applied topically remain major challenges. Objective: This exploratory study aimed to assess the efficacy and safety of a novel mix-activated anhydrous 0.1% retinal concentrate formulated also with hydrophilic active ingredients—N-acetyl glucosamine, niacinamide, ascorbic acid, and alpha-glucan oligosaccharide—in improving signs of skin aging over six weeks. Methods: A prospective, single-center study was conducted with 27 healthy adults (24 female and 3 male, aged 40–69 years, 21 with skin phototype III and 6 with phototype II) exhibiting visible signs of photoaging. Participants applied the retinal concentrate once daily, mixed in a 1:2 ratio with a moisturizer before application. Objective skin parameters, including pigmentation, fine lines, wrinkles, texture, volume, and pore visibility, were assessed using the Antera 3D imaging system at baseline and after six weeks. A self-evaluation questionnaire was completed at week six. Statistical significance was determined using the Wilcoxon signed-rank test (p < 0.05) and was corrected for multiple analyses. Results: Significant improvements were observed across all parameters: pigmentation (−12%, p < 0.0001), fine lines (−14%, p < 0.0001), wrinkle depth (−5%, p = 0.0045), skin texture (+12%, p < 0.0001), volume irregularities (−15%, p < 0.0001), and pore visibility (−24%, p < 0.0001). No significant change in redness was detected (p = 0.6664), indicating a good tolerability to the test product. Self-assessments reflected high user satisfaction: 81% reported improved skin appearance, 43% noted reduced need for makeup use, and 40% observed visible improvements already within two weeks. Conclusions: The anhydrous 0.1% retinal concentrate with hydrophilic actives significantly improved clinical signs of photoaging without causing irritation. The innovative mix-activated formulation stabilizes sensitive ingredients and enhances their efficacy, offering a novel, active, and well-tolerated approach to anti-aging skincare.